Clinical Trial Update: Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluated the safety and initial effectiveness of CNDO 201 Trichuris suis ova (TSO) for moderate to severe plaque psoriasis; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• CNDO 201 Trichuris Suis Ova (TSO) (Trichuris suis ova)

Snippet

Sponsor: Mark Lebwohl | Conditions: Psoriasis | Phase 1 | Status: COMPLETED